Intimation of Closure of Trading Window for the Quarter ending June 30, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Indrayani Biotech Ltd has announced the closure of its insider trading window for the quarter ending June 30, 2025. This is a standard regulatory compliance under SEBI's Prohibition of Insider Trading Regulations, 2015. During this closed period, designated persons including directors, promoters, key managerial personnel, and their immediate relatives are restricted from trading in the company's shares. The trading window typically remains closed until 48 hours after the declaration of quarterly financial results to the stock exchanges.
This is a routine compliance announcement with no direct impact on shareholders or stock price. Investors should note that company insiders will not be able to buy or sell shares until the Q1 FY26 results are officially announced.